https://www.selleckchem.com/pr....oducts/lirafugratini
ose levels in all three age subgroups, and the changes were maintained for up to 3 years in many individuals in each age subgroup. We found no additional safety or efficacy concerns among elderly patients beyond those already described in the package insert. The present results support the use of teneligliptin for the treatment of elderly patients with type 2 diabetes mellitus in real-world clinical practice.INTRODUCTION Adequate bowel preparation is a vital determinant for the success of colonoscopy. However, individuals who und
Like
Comment
Share
